<DOC>
	<DOCNO>NCT01002183</DOCNO>
	<brief_summary>The aim study evaluate role clindamycin artesunate possible combination partner fosmidomycin protect susceptibility recrudescent infection use monotherapy acute Plasmodium falciparum malaria retain excellent safety profile</brief_summary>
	<brief_title>Fosmidomycin With Clindamycin With Clindamycin Plus Artesunate</brief_title>
	<detailed_description>The scientific rationale use combination inhibit ability parasite synthesise isoprenoids , precursor many essential compound include sterol , carotenoid ubiquinone . This effected blockade non-mevalonate pathway fosmidomycin potent inhibitor 1-deoxy-D-xylulose 5-phosphate reductoisomerase couple target protein biosynthesis azithromycin bind 50S ribosomal subunit . This mode action contrast ability human host utilise mevalonate pathway isoprenoid synthesis account safety profile drug mechanism selective toxicity . Moreover affords protection cross resistance exist chemotherapeutic agent .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fosfomycin</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<criteria>male female subject age 15 55 year body mass index ≥ 18.5kg/M2 uncomplicated P falciparum malaria acute manifestation asexual parasitaemia 500uL 100,000uL ability tolerate oral therapy able give inform sign consent sign severe malaria , accord WHO criteria body mass index ≤ 18.5kg/M2 pregnancy history positive urine test lactation mixed plasmodial infection concomitant disease mask assessment response , include diabetes , uncontrolled hypertension , heart failure , hepatic dysfunction ( alanineamino transferase &gt; 150 U/L ) , renal impairment ( creatinine &gt; 125umol/L 3mg/dl ) haemoglobin &lt; 8g/dl white cell count &gt; 12000/uL antimalarial treatment within previous 28 day symptomatic AIDS</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>acute uncomplicated</keyword>
</DOC>